±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1950  |  »Ø¸´: 41
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û25´Î£¬×÷Õßcxsky315Ôö¼Ó½ð±Ò 23 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

cxsky315

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] ¡¾Ô­´´¡¿¡¶Drug stereochemistry analytical methods and pharmacblogy¡·

ºÃÊéÒ»±¾£¬²»¸Ò¶ÀÏí£¨ÒѾ­Õ¾ÄÚËÑË÷ÎÞÖØ¸´£©£¬ÓÈÆä×öÊÖÐÔÒ©ÎïµÄ£¬·ÖÀëµÄ´óÏÀÃǸϽôÏÂŶ£¬ÏÂÍêÁô¸öÓ¡¶ùŶ..........
thanks £¡£¡£¡.............

Name:¡¶Drug stereochemistry analytical methods and pharmacblogy¡·
          -- 2nd ed., rev. and expanded
Editer: Irving W. Wainer. -- 2nd ed., rev. and expanded.
page£º443
ISBN 0-8247-8819-2 (allc. paper)
±¾ÊéµÚÒ»°æ¾ÍԤʾÁËÒ©ÎïÁ¢Ìå¹¹ÏóÔÚʵ¼ÊÓ¦ÓÃÖеÄÖØÒªÐÔ£¬ÔÚ¹ýÈ¥µÄ¼¸ÄêÀÕâÒ»ÍÆ²â³ÉΪÁËÏÖʵ¡£Á¢Ì廯ѧҲ¾Í˳Àí³ÉÕµijÉΪÁ˼¸ºõËùÓÐҩѧ¿ÆÑ§Ñо¿µÄÖ÷Ì⣬Õâ·½Ãæ³öÏÖÁË´óÁ¿µÄÊé¼®ÔÓÖ¾£º¡¶natural andb iological science¡·¡¶Chirality¡· and ¡¶Tetrahedron Asymmetry¡·Ïà¹ØµÄѧÊõ»áÒéºÍ¸ßУ¿Î³Ì¸üÊÇÓêºó´ºËñ°ã³öÏÖ¡£Ä¿Ç°Å·ÖÞ£¬±±ÃÀ£¬ÈÕ±¾µÄÒ©Îï¹ÜÀí»ú¹¹ÔÚÒ©ÎïÁ¢ÌåÒì¹¹µÄÒ©Àí¶¾ÀíÑо¿Ïà¶Ô¸ü¶à£¬³É¹ûµ±È»Ò²¾Í¶àÁË£¨Ï£Íû¹úÄڵijæÓÑÃǶà¶àŬÁ¦°¡£¬ÔçÈÕ°ÚÍÑ¡°·Â֯׍¼Ò¡±µÄ¡°ÈÙÓþ³ÆºÅ¡±Å¶£¬¼ÓÓÍ£¡£¡£¡£¡£©
¶øµÚ¶þ°æ£¨¼´±¾Êé¸üÊǽ«Á¢Ì廯ѧ×÷ΪҩÎïÑз¢ºÍÒ©Àí·ÖÎöµÄÖØµã£¬ÆäÖÐ4~~6Õ¶ÔÁ¢ÌåÒì¹¹µÄ²ãÎö¼¼Êõ×öÁË´óÁ¿µÄ²ûÊö£¬µÚ°ËÕ£¬½²ÊöÁËÊÇÒ©ÎïµÄø´ß»¯Òì¹¹Ìåת»¯ºÏ³É£¬µÚ¾ÅÕ½²ÊöÒ©ÎïÁ¢ÌåÒì¹¹ÌåµÄ¶¾ÀíÒÔ¼°ÉúÎïת»¯¡£µÚÊ®£¬Ê®Ò»ÃèÊöÁËÁ¢Ìåת»¯ÒÔ¼°ÉúÎïÀûÓöȺÍÉúÎïµÈЧÐÔ¡£µÚÊ®¶þÕÂÔò½²ÊöÁ˵°°×ÖÊÖеÄÁ¢Ìå½áºÏ£¬Ê®Èýµ½Ê®ÁùÕÂÔòÖØµã½éÉÜÁ¢ÌåÒì¹¹µÄÒ©ÎïµÄµ÷Õû£¬¹¤ÒµÉú²ú£¬ÒÔ¼°ÊÖÐÔÎÊÌâ¡£
PREFACE TO THE SECONDED ITION.
The first edition of this book contained the observation that the stereoisomeric
compositioonf drug substancesw as rapidly becoming a key issue
in the development, approvaln, d clinical useo f pharmaceuticals. During
the past four years, this assertion has become a reaanlidty s, tereochemistry
is now a major theme in all branches of pharmaceutical science. The
interest in this topic is reflected in the content of articles appearing in
natural andb iological science journaalns d two new international journals,
Chirality and Tetrahedron Asymmetry. Moreover, a variety of conferences
and courses have been devoted to this subjecInt. addition, the European,
North American, and Japanese drug regulatory agencies have expressed
an interest in a closer examination of the stereoisomeric composition of
chiral drugs and the therapeutic and toxicological consequences of this
composition. The pharmaceuticailn dustry has quickly respondedto this
situation by considering stereochemistry in its initial drug evaluation
strategies. In fact, at the present time, a numofb ecro mpanies have made
the decision to market only single-isomer drugs.
In lighto f these developments,w e felt that iwt as necessary to review
the contenot f the first edition aton du pdate or supplement the information
presented in this work. The new topics examineidn this edition include:
(1) enzymatic synthesis and resolution of enantiomerically pure compounds
(Chapter 8); (2) toxicological consequences and implications of
stereoselective biotransformations (Chapter 9); (3) stereoselective transport
across epithelia (Chapter 10)(;4 ) anssde ssment of bioavailabilitya nd
bioequivalence of stereoisomeric drugs (Chapter 11).,The chapter on stereoselective
protein binding (Chapter 12) has been completely rewrainttedn
new contributions are presented on the regulatory, induasntrdia cl,l inical
aspects of stereoisomeric drugs (Chapters 13-16). In addition, the chapters
Ix
X Preface to the Second Edition
discussing stereoselective chromatographic separations (Chapters 4-6)
have been revised and expanded.
As with all volumes of this type, this project could not have been
completed without the contributors, and I would like to thank them for
their superb effortsI. am indebted to thef ollowing people for their help:
Ann Samson, David Lloyd, CamillGe rand, Karen Fried, Hiltrud Fieger,
Tanja Alebic-Kolbah, Anne-Francoise Aubry Gabriella Masolini, Xiao
Ming Zhang, and Pierre Wong. The assistance of the publisher's staff is
also appreciated, particularly the efforts of Sandra Beberman, Assistant
Vice President, Editorial, and Ted Allen, the production editor.
                                                                    Irving W. Wainer
ÏÂÔØµØÖ·£ºhttp://g.zhubajie.com/urllink.php?id=4850325f4twftla236unus6

»òÕߣºDrug Stereochemistry - Analytical Methods and Pharmacology 2nd ed - I. Wainer (Marcel Dekker_ 1993) WW.rar

»òÕߣºhttp://www.namipan.com/d/30cc62f ... f4002c9828a0c2a9d03

[ Last edited by cxsky315 on 2009-4-20 at 01:46 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

cxsky315

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)


¡ï
yestering(½ð±Ò+1,VIP+0):¹ÄÀøÂ¥Ö÷¶Ô×ÊÔ´µÄ¹Ø×¢£¬Äܼ°Ê±°ï³æ×Ó½â¾öÎÊÌâ 4-18 23:03
PDF µÄ£¬ÎÒÀ´¿´¿´£¬¿ÉÄÜÊÇÍøÅ̲»Îȶ¨£¬ÎÒÖØ´«Ò»´Î£¬×î½üÉÏ´«×ÜÊdzöÎÊÌâ

[ Last edited by cxsky315 on 2009-4-18 at 20:09 ]
5Â¥2009-04-18 20:06:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 42 ¸ö»Ø´ð

whwxj

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

£¡
ÏÂÔØºó´ò²»¿ª£¬Ê²Ã´¸ñʽµÄ£¿
4Â¥2009-04-18 20:02:23
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

whwxj

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)


Â¥Ö÷ÕæÊǺÃÈ˰¡£¡Ð»Ð»
6Â¥2009-04-18 20:14:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yjwu1982

½ð³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

Ö§³Ö
Â¥Ö÷´óºÃÈ˰¡ £¡
8Â¥2009-04-18 23:12:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085602 »¯¹¤×¨Ë¶ 338·Ö Çóµ÷¼Á +12 ·³ÕСç÷ 2026-03-27 12/600 2026-03-28 15:41 by L135790
[¿¼ÑÐ] 347Çóµ÷¼Á +3 ɽ¶¥¼û¦Á 2026-03-25 3/150 2026-03-28 14:13 by ÌÆãå¶ù
[¿¼ÑÐ] 352·Ö »¯¹¤Óë²ÄÁÏ +5 º£Äɰٴ¨Ly 2026-03-27 5/250 2026-03-28 03:39 by fmesaito
[¿¼ÑÐ] Ò»Ö¾Ô¸ Î÷±±´óѧ ×Ü·Ö282 Ó¢ÓïÒ»62 Çóµ÷¼Á +7 18419759900 2026-03-25 8/400 2026-03-27 16:38 by 18419759900
[¿¼ÑÐ] ²ÄÁÏ292µ÷¼Á +12 éÙËÌ˼ÃÀÈË 2026-03-23 12/600 2026-03-27 15:44 by caszguilin
[¿¼ÑÐ] °²»Õ´óѧר˶ÉúÎïÓëҽҩרҵ(086000)324·Ö£¬Ó¢ÓïÒѹýËÄÁù¼¶£¬Áù¼¶521£¬Çóµ÷¼Á +4 ÃÀζ¿ÉÀÖ¼¦³á 2026-03-26 4/200 2026-03-27 15:27 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[¿¼ÑÐ] 085600£¬²ÄÁÏÓ뻯¹¤321·Ö£¬Çóµ÷¼Á +9 ´ó²öС×Ó 2026-03-27 9/450 2026-03-27 14:30 by mmm just
[¿¼ÑÐ] 276Çóµ÷¼Á¡£ÓаëÄêµç³ØºÍ°ëÄê¸ß·Ö×Óʵϰ¾­Àú +10 ²ÄÁÏѧ257Çóµ÷¼Á 2026-03-23 11/550 2026-03-27 10:13 by YCIT- LHL
[¿¼ÑÐ] 359Çóµ÷¼Á +4 ÍõÁ˸öéª 2026-03-25 4/200 2026-03-27 08:43 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏѧ˶£¬Çóµ÷¼Á 6+5 ÌǺù«888ll 2026-03-22 10/500 2026-03-27 08:18 by hypershenger
[¿¼ÑÐ] ´ò¹ýºÜ¶à¾ºÈü£¬085406¿ØÖƹ¤³Ì300·Ö£¬Çóµ÷¼Á +3 askeladz 2026-03-26 3/150 2026-03-26 09:08 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉϺ£½»´óÉúÎïÓëҽҩר˶324·Ö£¬Çóµ÷¼Á +6 jiajunX 2026-03-22 6/300 2026-03-25 23:05 by licg0208
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +3 Çñgl 2026-03-25 3/150 2026-03-25 19:03 by Ainin_
[¿¼ÑÐ] ¿¼ÑÐÒ»Ö¾Ô¸ËÕÖÝ´óѧ³õʼ315£¨Ó¢Ò»£©Çóµ÷¼Á +3 sbdksD 2026-03-24 4/200 2026-03-25 18:16 by xcjcqu
[¿¼ÑÐ] 0854AI CV·½ÏòÕÐÊÕµ÷¼Á +4 ÕÂСÓã567 2026-03-23 4/200 2026-03-25 17:04 by CoderLoser
[¿¼ÑÐ] Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏÓ뻯¹¤303·ÖÇóµ÷¼Á +4 Ϊѧ666 2026-03-24 4/200 2026-03-25 11:27 by BruceLiu320
[¿¼ÑÐ] ÉϺ£µçÁ¦´óѧ²ÄÁÏ·À»¤ÓëвÄÁÏÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÑо¿Éú£¨²ÄÁÏ¡¢»¯Ñ§¡¢µç»¯Ñ§£¬»·¾³£© +4 ÎÒ°®Ñ§µç³Ø 2026-03-23 4/200 2026-03-25 00:59 by 1027_324
[¿¼ÑÐ] 335Çóµ÷¼Á +4 yuyuÓî 2026-03-23 5/250 2026-03-23 23:49 by Txy@872106
[¿¼ÑÐ] 361Çóµ÷¼Á +3 Glack 2026-03-22 3/150 2026-03-23 22:03 by fuyu_
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û